A Trial to Evaluate Tolerability and Immunogenicity of V540D in Healthy Adults (V540D-004)
Clinical trial NCT06688058 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06688058
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-20
- Primary completion
- 2026-11-30
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.